Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

What's new in Cardiology? Highlights from the 19th Congress of the European Society of Cardiology

Sep. 1, 1997

First approval for irbesartan

Sep. 1, 1997

Innothera discloses more agents for venous function deficiency

Aug. 29, 1997

SYST-EUR trial results presented

Aug. 29, 1997

DIAMOND CHF study results reported

Aug. 29, 1997

Val-HeFT will evaluate valsartan in CHF

Aug. 28, 1997

Gensia's injectable diltiazem receives ANDA approval

Aug. 28, 1997

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

Aug. 28, 1997

Parke-Davis initiates QUASAR trial of quinapril

Aug. 28, 1997

Cardiovascular and antiarrhythmic activities of HNS-32

Aug. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026